The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A multicenter effort to identify driver mutations and employ targeted therapy in patients with lung adenocarcinomas: The Lung Cancer Mutation Consortium (LCMC).
Bruce E. Johnson
Consultant or Advisory Role - Acceleron Pharma; AstraZeneca; Chugai Pharma; Genentech; KEW Group; Millennium; Pfizer; Transgenomic
Stock Ownership - KEW Group
Honoraria - Acceleron Pharma; AstraZeneca; Chugai Pharma; Genentech; Millennium; Pfizer; Transgenomic
Other Remuneration - Response Genetics
Mark G. Kris
Consultant or Advisory Role - Genentech; Novartis; Pfizer
Lynne D Berry
No relevant relationships to disclose
David J. Kwiatkowski
Consultant or Advisory Role - Novartis
Honoraria - Millennium
Research Funding - Millennium
Anthony John Iafrate
Consultant or Advisory Role - Bio-Reference Laboratories; Pfizer
Marileila Varella-Garcia
Honoraria - Abbott Molecular; Pfizer
Research Funding - Abbott Molecular; Boehringer Ingelheim; Merck Serono
Ignacio Ivan Wistuba
Consultant or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Johnson & Johnson; Pfizer; Roche; Sanofi
Wilbur A. Franklin
No relevant relationships to disclose
Marc Ladanyi
No relevant relationships to disclose
Pei-Fang Su
No relevant relationships to disclose
Lecia V. Sequist
No relevant relationships to disclose
Fadlo Raja Khuri
No relevant relationships to disclose
Edward B. Garon
No relevant relationships to disclose
William Pao
Consultant or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Clovis; MolecularMD; Symphony Evolution
Research Funding - AstraZeneca; Bristol-Myers Squibb; Clovis; Enzon; Symphogen; Xcovery
Other Remuneration - MolecularMD
Charles M. Rudin
Consultant or Advisory Role - Lilly; Oncothyreon
Joan H. Schiller
No relevant relationships to disclose
Eric B. Haura
No relevant relationships to disclose
Giuseppe Giaccone
No relevant relationships to disclose
John D. Minna
Consultant or Advisory Role - Amgen
Paul A. Bunn
Consultant or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; GlaxoSmithKline; Lilly; Merck; Novartis; Pfizer; Roche; Sanofi